Biodexa Pharmaceuticals
BDRXCardiff, United Kingdom· Est. 2014
Biodexa Pharmaceuticals develops targeted drug delivery technologies to improve the efficacy and safety of existing oncology and rare disease treatments.
BDRX · Stock Price
USD 0.660.04 (-5.85%)
Market Cap: $587K
Historical price data
About
Biodexa Pharmaceuticals develops targeted drug delivery technologies to improve the efficacy and safety of existing oncology and rare disease treatments.
NanotechnologySmall MoleculesVaccines
Funding History
6Total raised:$49.5M
Grant$2MMay 15, 2022
PIPE$12MMar 15, 2021
Grant$2.5MMar 15, 2020
Series B$15MSep 15, 2017